Clinical Trial Update: Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study) [Phase 4]

View source ↗

Summary

Phase 4 ALFA study assessing whether alfacalcidol reduces falls in postmenopausal women with osteopenia or osteoporosis; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Alfacalcidol (alfacalcidol)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Osteoporosis, Postmenopausal, Osteopenia | Phase 4 | Status: COMPLETED